Time to Functional Loss as an Endpoint in Huntington's Disease Trials: Enrichment and Sample Size
{{output}}
Background: Clinical trial scenarios can be modeled using data from observational studies, providing critical information for design of real-world trials. The Huntington's Disease Integrated Staging System (HD-ISS) characterizes ... ...
